Modulation of immunostimulatory properties of oligonucleotide-based compounds by utilizing modified immunostimulatory dinucleotides
Details for Australian Patent Application No. 2004206820 (hide)
International Classifications
Event Publications
7 July 2005 PCT application entered the National Phase
PCT publication WO2004/064782 Priority application(s): WO2004/064782
23 March 2006 Assignment before Grant
Hybridon, Inc. The application has been assigned to Idera Pharmaceuticals, Inc.
10 June 2010 Application Accepted
Published as AU-B-2004206820
7 October 2010 Standard Patent Sealed
Legal
The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.
Next and Previous Patents/Applications
2004206821-Compositions and methods for combination antiviral therapy
IP Reporting Samples
Customised IP Reporting
IP Insider for IP Professionals
IP Monitor Professional
- Editable Word format reports
- For IP Professionals
- Multiuser